Dr. Samer Zaid Kaylani
Claim this profileTexas Tech University Health Sciences Center-Amarillo
Studies Leukemia
Studies Tumors
12 reported clinical trials
45 drugs studied
Area of expertise
1Leukemia
BCR-ABL1 fusion positive
ABL-class fusion positive
Philadelphia chromosome positive
2Tumors
Affiliated Hospitals
Clinical Trials Samer Zaid Kaylani is currently running
Chemotherapy
for Wilms Tumor
This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo (ifosfamide, carboplatin, etoposide, cyclophosphamide, and topotecan) work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT (those treated with only 2 drugs for the initial WT) and regimen ICE/Cyclo/Topo has on patients with high and very high risk relapsed FHWT (those treated with 3 or more drugs for the initial WT).
Recruiting1 award Phase 212 criteria
Nivolumab + Chemo-Immunotherapy
for Large B-Cell Lymphoma
This phase III trial compares the effects of nivolumab with chemo-immunotherapy versus chemo-immunotherapy alone in treating patients with newly diagnosed primary mediastinal B-cell lymphoma (PMBCL). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of cancer cells to grow and spread. Treatment for PMBCL involves chemotherapy combined with an immunotherapy called rituximab. Chemotherapy drugs work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Giving nivolumab with chemo-immunotherapy may help treat patients with PMBCL.
Recruiting2 awards Phase 321 criteria
More about Samer Zaid Kaylani
Clinical Trial Related18 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Samer Zaid Kaylani has experience with
- Cyclophosphamide
- Etoposide
- Vincristine Sulfate
- Cytology Specimen Collection Procedure
- Radiation Therapy
- Dexamethasone
Breakdown of trials Samer Zaid Kaylani has run
Leukemia
Tumors
Cancer
Lymphoblastic Leukemia-Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samer Zaid Kaylani specialize in?
Samer Zaid Kaylani focuses on Leukemia and Tumors. In particular, much of their work with Leukemia has involved BCR-ABL1 fusion positive patients, or patients who are ABL-class fusion positive.
Is Samer Zaid Kaylani currently recruiting for clinical trials?
Yes, Samer Zaid Kaylani is currently recruiting for 2 clinical trials in Amarillo Texas. If you're interested in participating, you should apply.
Are there any treatments that Samer Zaid Kaylani has studied deeply?
Yes, Samer Zaid Kaylani has studied treatments such as Cyclophosphamide, Etoposide, Vincristine Sulfate.
What is the best way to schedule an appointment with Samer Zaid Kaylani?
Apply for one of the trials that Samer Zaid Kaylani is conducting.
What is the office address of Samer Zaid Kaylani?
The office of Samer Zaid Kaylani is located at: Texas Tech University Health Sciences Center-Amarillo, Amarillo, Texas 79106 United States. This is the address for their practice at the Texas Tech University Health Sciences Center-Amarillo.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.